Search
Now showing items 1-3 of 3
Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?
(BioMed Central, 2005)
Background: Our aim was to determinate bone mineral density (BMD), levels of biochemical markers and cytokines in children with chronic hepatitis B treated with interferon (IFN)-alpha and to investigate effect of IFN-alpha ...
Accelerated hepatitis B vaccination schedule in childhood
(Japan Pediatric Society, 2002)
Background: For children travelling to a hepatitis B virus (HBV) endemic area or before a treatment by blood or blood productions, the conventional HBV vaccination schedule takes too long to be completed. There may be ...
Comparison of two different regimens of combined interferon-?2A and lamivudine therapy in children with chronic hepatitis B infection
(International Medical Press, 2006)
Aim: To evaluate the efficacy of two regimens of combined interferon-alpha2a (IFN-alpha2a) and lamivudine (3TC) therapy in childhood chronic hepatitis B.
Methods: A total of 177 patients received IFN-alpha2a, 9 million ...
